Motley Fool
Vistance Networks Stock Up 250%. Here's Why a $40 Million Position Signals a Post-Divestiture Bet
📈
AI Sentiment
Highly Positive
9/10
- Home
- TBPH
as of 02-26-2026 9:30am EST
$19.26
+$0.20
+1.02%
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | GEORGE TOWN, GRAND CAYMAN |
| Market Cap: | 1.0B | IPO Year: | 2013 |
| Target Price: | $27.80 | AVG Volume (30 days): | 386.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.88 | EPS Growth: | N/A |
| 52 Week Low/High: | $7.90 - $21.03 | Next Earning Date: | N/A |
| Revenue: | $15,386,000 | Revenue Growth: | -68.37% |
| Revenue Growth (this year): | 70.9% | Revenue Growth (next year): | -6.60% |
| P/E Ratio: | 21.66 | Index: | N/A |
| Free Cash Flow: | -13670000.0 | FCF Growth: | N/A |
Latest Theravance Biopharma Inc. News
TBPH Breaking Stock News: Dive into TBPH Ticker-Specific Updates for Smart Investing
Compare TBPH vs Leading Stocks
See how TBPH stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "TBPH Theravance Biopharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.